Abbott Wants U.S. To Cough Up Docs In AWP Suit

Law360, New York (October 12, 2007, 12:00 AM EDT) -- Government action against the major drug companies over an alleged Medicare scam remains mired in a battle for documents, with pharmaceutical giant Abbott Laboratories Inc. demanding U.S. officials produce records explaining the rationale for relying on the industry's own prices.

The drug manufacturer has urged the Massachusetts judge overseeing the multidistrict litigation over the industry's average wholesale drug prices to compel the government to turn over documents detailing its decision to adopt, and keep, the reported prices as the basis for Medicare rebates on prescription medication....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.